US20050246010A1 - Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use - Google Patents
Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use Download PDFInfo
- Publication number
- US20050246010A1 US20050246010A1 US10/836,909 US83690904A US2005246010A1 US 20050246010 A1 US20050246010 A1 US 20050246010A1 US 83690904 A US83690904 A US 83690904A US 2005246010 A1 US2005246010 A1 US 2005246010A1
- Authority
- US
- United States
- Prior art keywords
- elongated member
- helical
- catheter
- vascular prosthesis
- ledge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- 230000002792 vascular Effects 0.000 claims abstract description 71
- 238000004804 winding Methods 0.000 claims description 14
- 229920000642 polymer Polymers 0.000 claims description 11
- 238000013519 translation Methods 0.000 claims description 9
- 238000006073 displacement reaction Methods 0.000 claims description 7
- 238000003780 insertion Methods 0.000 claims 3
- 230000037431 insertion Effects 0.000 claims 3
- 238000002788 crimping Methods 0.000 claims 2
- 230000004323 axial length Effects 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 230000008859 change Effects 0.000 description 6
- 206010002329 Aneurysm Diseases 0.000 description 5
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000036262 stenosis Effects 0.000 description 4
- 208000037804 stenosis Diseases 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 229920000271 Kevlar® Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009954 braiding Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000013152 interventional procedure Methods 0.000 description 1
- 239000004761 kevlar Substances 0.000 description 1
- 238000003698 laser cutting Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000013047 polymeric layer Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000012781 shape memory material Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/88—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
Definitions
- the present invention relates to a delivery catheter, and methods of use, for an implantable vascular ribbon-type prosthesis having a helical section and at least one anchor section, wherein the delivery system controls foreshortening of the prosthesis during deployment.
- Balloon expandable and self-expanding stents are well known for restoring patency in a stenosed vessel, e.g., after an angioplasty procedure, and the use of coils and stents are known techniques for treating aneurysms.
- Previously-known self-expanding stents generally are retained in a contracted delivery configuration using a sheath, then self-expand when the sheath is retracted.
- Such stents commonly have several drawbacks, for example, the stents may experience large length changes during expansion (referred to as “foreshortening”) and may shift within the vessel prior to engaging the vessel wall, resulting in improper placement.
- many self-expanding stents have relatively large delivery profiles because the configuration of their struts limits further compression of the stent. Accordingly, such stents may not be suitable for use in smaller vessels, such as cerebral vessels and coronary arteries.
- the stent described in the foregoing publication has several drawbacks. For example, due to friction between the turns and the sheath, the individual turns of the stent may bunch up, or overlap with one another, when the delivery sheath is retracted.
- U.S. Pat. No. 4,768,507 to Fischell et al. and U.S. Pat. No. 6,576,006 to Limon et al. each describe the use of a groove disposed on an outer surface of an interior portion of the stent delivery catheter, wherein at least a portion of the stent is disposed within the groove to prevent axial movement during proximal retraction of the sheath.
- a delivery catheter for use with a ribbon-type stent comprising an inner member slidably disposed within a sheath.
- the inner member includes a helical ledge that causes the stent to be wound around the inner member with a pitch selected to provide a preselected amount of foreshortening of the stent during deployment, including substantially zero foreshortening.
- the delivery catheter includes an inner member comprising a elongated flexible shaft having a helical wire affixed to its exterior surface, wherein the pitch of the helical wire is preselected for the stent to be delivered.
- the size of the gap between adjacent turns of the helical wire preferably causes the adjacent turns of the ribbon-type stent, when wound about the inner member, to overlap.
- the helical wire provides a ledge or abutment surface against which the ribbon-type stent may be urged during winding of the stent to its reduced-diameter delivery configuration.
- the helical wire may be arranged so either the proximal-facing or distal-facing surface of the helical wire defines the ledge.
- the inner member may have the abutment surface integrally formed with the exterior surface of the inner member. This may be accomplished by braiding a plurality of wire strands together, wherein one of the wire strands has a larger cross-section than the others. In this case, the larger cross-section wire protrudes from the inner member to define the helical ledge on the surface of the inner member.
- the helical ledge may be integrally formed with an inner member formed from a suitable polymer, e.g., by extrusion or molding.
- the delivery catheter of the present invention optionally may include an inflatable balloon disposed adjacent to the distal end of the inner member, and distal to the distal end of the sheath.
- the inflatable balloon may be deployed to engage a portion of a vessel so that proximal withdrawal of the sheath does not inadvertently result in axial displacement of the delivery catheter or stent relative to the vessel.
- the balloon distributes the load created by proximal withdrawal of the sheath uniformly to the circumference of the vessel, thereby reducing local stress concentrations during deployment of the stent that might otherwise arise where a partially-deployed stent contacts the vessel wall.
- the inner member may in addition include means for engaging a distal section of the stent against axial displacement during proximal retraction of the sheath.
- FIG. 1 is a perspective view of a vascular prosthesis suitable for use with the delivery catheter of the present invention
- FIG. 2 is a drawing depicting foreshortening of a ribbon-type stent as encountered with previously-known delivery systems as the stent expands from a contracted delivery configuration to an expanded deployed configuration;
- FIG. 3 is a drawing depicting a ribbon-type stent unrolled to a flat configuration and projected onto an expanded deployed configuration (for clarity, only a single turn is shown, although it will be understood that in the deployed configuration the stent includes multiple turns);
- FIG. 4 is a drawing depicting trigonometric relationships between the wrap angle of the stent of FIG. 3 and width of the stent;
- FIG. 5 is a side sectional view of a prior art delivery system having an inner member disposed within a sheath for relative sliding motion therebetween;
- FIG. 6 is a perspective view of a distal portion of an inner member for a delivery catheter constructed in accordance with the principles of the present invention.
- FIG. 7 is a side view of a distal portion of another inner member of a delivery catheter of the present invention, wherein the helical ledge is integrally formed with the inner member;
- FIG. 8 is a side view illustrating an optional balloon that may be used with the delivery catheter of the present invention to enhance stent placement.
- the present invention is directed to a delivery catheter for use with an implantable vascular prosthesis configured for use in a wide range of applications, such as treating aneurysms, maintaining patency in a vessel, and allowing for the controlled delivery of therapeutic agents to a vessel wall.
- the delivery catheter of the present invention may be used to deliver a vascular prosthesis having a helical ribbon portion joined, at its distal end, to a radially self-expanding anchor portion, such as depicted in FIG. 1 .
- the delivery catheter provides enhanced accuracy in delivering the stent by providing a predictable degree of foreshortening of the stent, including substantially zero foreshortening.
- the delivery catheter optionally may include a balloon that reduces inadvertent axial movement of the delivery catheter during stent deployment and/or means that reduce axial displacement of the vascular prosthesis relative to the delivery catheter.
- vascular prosthesis 10 is described in copending commonly assigned U.S. patent application Ser. No. 10/342,427, filed Jan. 13, 2003, and comprises helical section 12 and distal section 14 , each capable of assuming contracted and deployed states. In FIG. 1 , helical section 12 and distal section 14 are each depicted in their respective deployed states.
- Vascular prosthesis 10 preferably is formed from a solid tubular member comprising a shape memory material, such as nickel-titanium alloy (commonly known in the art as Nitinol).
- the solid tubular member then is laser cut, using techniques that are per se known in the art, to a desired deployed configuration, as depicted in FIG. 1 .
- An appropriate heat treatment, per se known in the art, then may be applied to vascular prosthesis 10 while the device is held in the desired deployed configuration (e.g., on a mandrel), thus conferring a desired deployed configuration to vascular prosthesis 10 when self-deployed.
- Distal section 14 preferably has a generally zig-zag configuration in the deployed state, wherein the zig-zag configuration preferably is formed by laser cutting a solid tube to form a pattern comprising plurality of arcuate struts 18 joined at apices 20 .
- Distal section 14 is designed to be deployed from the delivery catheter of the present invention first to fix the distal end of the stent at a desired known location within a vessel. In this manner, subsequent deployment of helical section 12 of the stent may be accomplished with greater accuracy.
- Helical section 12 preferably comprises a helical mesh configuration that includes a plurality of substantially flat turns 22 .
- Plurality of turns 22 may include a multiplicity of openings, as illustrated by openings 24 . It should be understood that the configuration of helical section 12 depicted in FIG. 1 is merely illustrative, and other patterns may be advantageously employed.
- Helical section 12 is coupled to distal section 14 at junction 26 .
- foreshortening refers to the length change of the stent between its contracted delivery configuration and its expanded deployed configuration. More specifically, the contracted delivery configuration, depicted in the upper portion of FIG. 2 , corresponds to the state wherein consecutive turns of the stent have been tightly wrapped around adjacent turns to reduced the diameter of the stent to diameter d 1 and length of L 1 , suitable for transluminal delivery to a target location within a vessel.
- the stent In the deployed configuration, the stent is permitted to expand to its nominal working diameter, and has a diameter d 2 and length of L 2 , suitable for supporting a target location within a vessel. “Foreshortening” is defined as the difference between the lengths L 1 and L 2 .
- ribbon-type stents often are wound down around a delivery catheter in either an “edge to edge” manner (where the edges of adjacent turns lie next to one another) or with an overlap (or “shingled”), and then covered with a sheath that restrains the stent in the contracted delivery configuration.
- edge to edge the stent may be significantly longer in the contracted delivery configuration than in the deployed configuration, and thus result in significant foreshortening when deployed.
- the turns of the stent when the turns of the stent are permitted to overlap in the contracted delivery configuration, the turns of the stent may lock or bind within the delivery system during deployment. Further still, in either method of contracting the stent to its contracted delivery configuration, the stent has a tendency to jump or hop forwards or backwards when deployed, resulting in poor control. Thus, previously-known ribbon-type stents generally are perceived to be capable of less accurate deployment than conventional balloon expandable stents.
- Vascular prosthesis 10 of FIG. 1 is designed to address the issue of movement of the distal end of the stent.
- distal section 10 functions as a anchor that fixes the distal end of the stent to the vessel wall.
- the delivery catheter of the present invention provides the rest of the solution to the placement problem by controlling winding of the stent to a predetermined contracted delivery configuration, and likewise controlling unwinding of the stent during deployment to mitigate foreshortening.
- the stent 30 ′ When deployed, as schematically depicted by the single turn in the upper portion of the FIG. 3 , the stent 30 ′ comprises a strip of material wrapped cylindrically at a diameter (d) over an axial length (L) for a number of revolutions (n). The strip is wrapped at a wrap angle ( ⁇ ), which may be measured from a plane normal to the axis of the helix.
- the strip has a width ( ⁇ ) and an edge length (E); these are physical characteristics of the stent that do not change.
- the diameter (d), wrap angle ( ⁇ ), number of revolutions (n), and axial length (L) are interrelated characteristics that vary depending upon the helical configuration of the stent.
- the diameter of the stent varies between the contracted delivery configuration and deployed configuration, which as shown in FIG. 2 also may effect the wrap angle, number of revolutions, and axial length.
- the axial length of the stent in the helical configuration is L plus the proximal-most part of the projected strip width.
- This additional length may be computed as depicted in FIG. 4 , using a right triangle in which one leg is the strip width ( ⁇ ), and the hypotenuse is the strip width projected onto the helical axis of the stent. Because the angle on the right side of this triangle is equal to the wrap angle ( ⁇ ), the strip width projected onto the helical axis of the stent is equal to ⁇ /cos ⁇ .
- the total length of the stent in the helical configuration is therefore L+ ⁇ /cos ⁇ .
- the projected width of the strip also increases.
- foreshortening may be computed as the change in the axial length of the stent as it transitions from one diameter (d 1 ) to another (d 2 ) during deployment:
- F ( L 1 + ⁇ /cos ⁇ 1 ) ⁇ ( L 2 + ⁇ /cos ⁇ 2 )
- F ( L 1 ⁇ L 2 )+( ⁇ /cos ⁇ 1 ⁇ /cos ⁇ 2 ) From inspection of FIG.
- F ( E sin ⁇ 1 ⁇ E sin ⁇ 2 )+( ⁇ /cos ⁇ 1 ⁇ /cos ⁇ 2 )
- F E (sin ⁇ 1 ⁇ sin ⁇ 2 )+ ⁇ (1/cos ⁇ 1 ⁇ 1/cos ⁇ 2 )
- Delivery catheter 40 is disclosed, e.g., in U.S. Pat. No. 4,665,918 to Garza et al., and includes inner member 41 having central lumen 42 , nose cone 43 and sheath 44 .
- Catheter 41 includes recessed portion 45 that cooperates with sheath 44 to retain the stent in its contracted delivery configuration for transluminal delivery.
- Delivery catheter 40 also may comprise fluid delivery lumen 47 , which may be used to deliver chilled saline via one or more ports 48 to the stent during delivery.
- Delivery catheter 50 constructed in accordance with the principles of the present invention, is described.
- Delivery catheter 50 includes sheath 51 and inner member 52 that implements the rule described hereinabove to mitigate or eliminate foreshortening by imposing on the stent, by imposing on the stent in the contracted delivery configuration the wrap angle ⁇ that the stent will have in the deployed configuration.
- Inner member 52 illustratively comprises braided wire tube 53 having helical wire 54 affixed to its outer surface to form helical ledge 55 , for example, using a biocompatible adhesive or solder.
- helical wire 54 may be laminated to the outer surface of braided wire tube 53 using a polymeric layer, or inner member 52 itself may be formed by sandwiching a helical wire between inner and outer polymeric layers.
- braided tube 53 and helical wire 54 could be replaced with an inner member having an exterior surface including an integrally formed ridge.
- helical ledge 55 could be formed by other features such as protrusions extending from the surface of the inner member.
- Provision of the helical ledge directly on the exterior surface of the inner member as in the embodiment of FIG. 6 permits a definable deployment length of the stent, namely, zero foreshortening.
- the helical ledge also provides linear resistance to stent migration when sheath 51 is retracted during stent deployment. This engagement between the turns of the stent and the inner member maintains the linear stability of the stent, and reduces the risk that overlapping turns of the stent do not bunch up or seize against the interior surface of the sheath.
- the helical ledge ensures that the stent unwinds on its axis but does not experience significant linear change along the axis.
- the delivery catheter of FIG. 6 Use of the delivery catheter of FIG. 6 is as follows: starting at one end of the stent and helical ledge 55 , the stent is wound around the inner member to its contracted delivery configuration while an edge of the stent is abutted against ledge 55 . This causes each subsequent turn of the stent to overlap the preceding turn. The amount of overlap of adjacent turns of the stent is defined by the helical ledge, and is a feature of the particular design of the stent. When the stent is wound down to its contracted delivery configuration, sheath 51 is advanced over the stent and inner member to retain the stent in its contracted delivery configuration. When loaded in the delivery catheter, the length of the stent is the same as the length of the stent in the deployed configuration.
- the specific steps for winding the stent onto the inner member in a proximal to distal direction are as follows: First, the tail of the stent is located and fixed at the proximal end of the stent area of the inner member with the distal edge of the stent abutted against the helical ledge. Next, the stent is wrapped around the inner member using the helical ledge to control the pitch and overlap of the stent. The sheath is then slid over the stent while being rotated in a direction in which the stent is wrapped. Finally, if a stent as depicted in FIG.
- the anchor portion of the stent is crimped down, and the sheath is slid over the anchor portion to retain the stent in the contracted delivery configuration.
- the helical ledge guides the pitch of the stent as it is wrapped, thus providing a zero foreshortening solution.
- another method of using delivery catheter 50 calls for winding the stent onto the inner member in a distal to proximal direction, as follows: First, the anchor portion of the stent is placed on inner member in a desired location, and the joint between anchor portion and the helical body portion of the stent is temporarily fixed to the inner member.
- the proximal portion of the stent is wrapped around the inner member, wherein the proximal edge of the stent is abutted against the helical ledge.
- the sheath is slid over the stent and inner member while rotating the sheath in the direction in which the stent is wound.
- the sheath is advanced up to the joint where the distal anchor portion of the stent is coupled to the helical proximal portion.
- the anchor portion then is crimped down onto the inner member, and the sheath is advanced, while being rotated in the direction of the wrap, until it covers the anchor portion.
- the helical ledge not only mitigates foreshortening, but in addition, the proximal edge of the stent is prevented from sliding in the proximal direction during retraction of the sheath to deploy the stent.
- Inner member 52 ′ also preferably comprises an elongated braided tube 53 ′ having helical wire 54 ′ integrally formed with the tube to define helical ledge 55 ′.
- Braid 53 ′ preferably is sandwiched between polymeric inner and outer liners, and is made up of a plurality of wire members braided together around the inner liner.
- the wires used to construct braid 53 ′ may have flat or round wires cross-sections, and may comprise stainless steel or polymeric strands, e.g., such as polyester or Kevlar, depending on the flexibility and rigidity desired for inner member 53 ′.
- the rigidity of the inner member may be further selected by choice of the wire diameter, number used and the tightness of the pitch of the braid.
- Helical ledge 55 ′ is formed by increasing the diameter of one of the wires used to construct the braid of tube 53 ′, so that it protrudes from the exterior surface of the completed inner member.
- the number of braid members and the tightness of their pitch may be selected so that helical wire 54 ′ forms helical ledge 55 ′ that imposes a selected wrap angle on the stent when wound in accordance with the above-described methods.
- the inner member may be formed of a polymeric material so that its exterior surface includes an integrally formed ledge, e.g., by extrusion or molding.
- Inner member 52 ′ of FIG. 7 permits the delivery catheter to be easily customized during manufacture to provide a desired degree of foreshortening of the stent, including zero foreshortening.
- inner member 52 ′ avoids the manufacturing difficulties inherent in the design of FIG. 6 , by eliminating the step of affixing the helical wire to the inner member.
- inclusion of helical wire 54 ′ in braided tube 53 ′ over the length of the inner member advantageously provides for better interaction between the inner member and sheath by providing fewer points of contact therebetween and therefore less frictional engagement between the two members.
- the amount of foreshortening between two different helical configurations may be determined by selection of the wrap angles ⁇ 1 and ⁇ 2 to provide any desired degree of foreshortening or length increase of the stent as may be desired.
- the delivery catheter of the present invention is configured to reduce the possibility of inadvertent axial translation of the delivery catheter during an initial phase of stent deployment, i.e., prior to deployment of distal section 14 of the stent of FIG. 1 .
- inner member 60 of the present invention includes a portion defining a helical ledge, as in the embodiments of FIGS. 5 and 6 , and further comprising optional balloon 61 disposed adjacent to distal end 62 .
- Radio-opaque marker 63 is affixed to the distal end of inner member 60 to make the distal end of the inner member visible under fluoroscopic imaging.
- Balloon 61 may be formed from compliant or semi-compliant materials, such as nylon or PEBAX, and is inflated via 64 .
- Lumen 64 may be pressurized with fluid from syringe or inflator 65 , which may be selectively coupled to the proximal end of inner member 60 , as is known in the art.
- inner member 60 further includes means for engaging the distal end of the distal section of stent 10 .
- the means for engaging comprises polymer layer 66 that has been treated, e.g., by formulation, mechanical abrasion, chemically or by heat treatment, to make the polymer tacky or otherwise enhance the grip of the material.
- polymer layer 66 comprises a proximal shoulder of balloon 62 , although the polymer layer alternatively may be formed and applied separately from balloon 61 .
- balloon 61 may be omitted, and polymer layer 66 may be disposed on a portion of the inner member adjacent the distal end 62 .
- the delivery catheter of the present invention including inner member 60 , is advanced along a guide wire into a vessel containing a treatment area. Positioning of the vascular prosthesis relative to the treatment area is confirmed using radio-opaque marker 63 .
- sheath 51 (see FIG. 6 ) is retracted proximally to permit distal section 14 of stent 10 to deploy.
- polymer layer 66 grips distal section 14 of stent 10 , thereby preventing distal section 14 from being dragged proximally into engagement with helical section 12 during retraction of the sheath. Instead, polymer section 66 grips distal section 14 against axial movement, and permits the distal section to expand radially outward into engagement with the vessel wall once the sheath is retracted.
- balloon 61 may be expanded to contact the vessel wall. Balloon 61 therefore anchors distal end 63 of the delivery catheter relative to the vessel wall, so that no inadvertent axial displacement of the delivery catheter arises during proximal retraction of the sheath to release distal section 14 or helical section 12 of stent 10 .
- Stent 80 is disposed in its delivery configuration compressed around inner member 72 having a helical ledge, and retained by sheath 71 .
- Distal section 81 of stent 80 is disposed in contact with polymer layer 73 to prevent relative axial movement therebetween.
- delivery catheter 70 is percutaneously and transluminally advanced along guide wire 90 until tip 74 of the catheter is disposed within adjacent healthy tissue of vessel V, distal of lesion L, e.g., as determined by fluoroscopic imaging.
- Balloon 75 then is inflated to engage the vessel wall and prevent axial displacement of the delivery catheter during subsequent retraction of sheath 71 .
- Polymer layer 73 engages distal section 81 of stent 80 , thereby preventing axial displacement of distal section 81 during retraction of sheath 71 .
- sheath 71 is retracted proximally until distal section 81 self-expands into engagement with vessel wall within or distal to lesion L. Proximal movement of sheath 71 may be halted once radio-opaque marker 76 of sheath 71 is substantially aligned with radio-opaque marker 77 of inner member 72 . When released from the constraint provided by sheath 71 , the struts of distal section 81 expand in a radial direction to engage the interior of vessel V.
- sheath 71 is further retracted proximally to cause the helical section of stent 80 to unwind and deploy to its predetermined shape within vessel V.
- the turns of the helical section of the stent unwind and engage and conform to an inner wall of vessel V in a controlled manner.
- inner member 72 includes a helical ledge (not shown) as described hereinabove with respect to FIGS. 5 and 6 , the stent experiences little or no foreshortening.
- any forces that might be applied to distal section 81 during retraction of sheath 71 advantageously are uniformly distributed over the surface of balloon 75 , thereby reducing the risk of insult to the vessel endothelium.
Abstract
Description
- The present invention relates to a delivery catheter, and methods of use, for an implantable vascular ribbon-type prosthesis having a helical section and at least one anchor section, wherein the delivery system controls foreshortening of the prosthesis during deployment.
- Today there are a wide range of intravascular prostheses on the market for use in the treatment of aneurysms, stenosis, and other vascular irregularities. Balloon expandable and self-expanding stents are well known for restoring patency in a stenosed vessel, e.g., after an angioplasty procedure, and the use of coils and stents are known techniques for treating aneurysms.
- Previously-known self-expanding stents generally are retained in a contracted delivery configuration using a sheath, then self-expand when the sheath is retracted. Such stents commonly have several drawbacks, for example, the stents may experience large length changes during expansion (referred to as “foreshortening”) and may shift within the vessel prior to engaging the vessel wall, resulting in improper placement. Additionally, many self-expanding stents have relatively large delivery profiles because the configuration of their struts limits further compression of the stent. Accordingly, such stents may not be suitable for use in smaller vessels, such as cerebral vessels and coronary arteries.
- Other drawbacks associated with the use of coils or stents in the treatment of aneurysms is that the devices, when deployed, may have a tendency to straighten or otherwise remodel a delicate cerebral vessel, which may cause further adverse consequences. Moreover, such devices may not adequately reduce blood flow from the cerebral vessel into the sac of the aneurysm, which may increase the likelihood of rupture.
- For example, PCT Publication WO 00/62711 to Rivelli describes a stent comprising a helical mesh coil having a plurality of turns and including a lattice having a multiplicity of pores. The lattice is tapered along its length. In operation, the plurality of turns are wound into a reduced diameter helical shape, then constrained within a delivery sheath. The delivery sheath is retracted to expose the distal section of the stent and anchor the distal end of the stent. As the delivery sheath is further retracted, subsequent individual turns of the stent unwind to conform to the diameter of the vessel wall.
- The stent described in the foregoing publication has several drawbacks. For example, due to friction between the turns and the sheath, the individual turns of the stent may bunch up, or overlap with one another, when the delivery sheath is retracted. U.S. Pat. No. 4,768,507 to Fischell et al. and U.S. Pat. No. 6,576,006 to Limon et al., each describe the use of a groove disposed on an outer surface of an interior portion of the stent delivery catheter, wherein at least a portion of the stent is disposed within the groove to prevent axial movement during proximal retraction of the sheath.
- While the delivery catheters disclosed in the foregoing patents prevent axial movement and bunching of the prosthesis during retraction of the sheath of the delivery catheter, those systems do not effectively address the issue of stent foreshortening. In particular, once the sheath of the delivery catheter is fully retracted, the turns of a ribbon-type stent may shift relative to one another within the vessel prior to engaging the vessel wall, resulting in inadequate coverage of the stenosis.
- In view of the drawbacks of previously known ribbon-type stent delivery systems, it would be desirable to provide a delivery catheter that controls axial movement of a ribbon-type stent within the catheter during deployment.
- It also would be desirable to provide a delivery catheter suitable for use with ribbon-type stents that provides a predictable amount of foreshortening of the stent during delivery, thereby improving accuracy of stent deployment.
- It further would be desirable to provide a delivery catheter suitable for use with ribbon-type stents that mitigates foreshortening of the stent during delivery, and thus enhances the ability of a stent of predetermined length to provide adequate coverage of a stenosis.
- In view of the foregoing, it is an object of the present invention to provide a delivery catheter for use with a ribbon-type stent that controls axial movement of the stent within the catheter during deployment.
- It is another object of this invention to provide a delivery catheter suitable for use with ribbon-type stents that provides a predictable amount of foreshortening of the stent during delivery, thereby improving accuracy of stent deployment.
- It is a further object of the present invention to provide a delivery catheter suitable for use with ribbon-type stents that mitigates foreshortening of the stent during delivery, and thus enhances the ability of a stent of predetermined length to provide adequate coverage within of a stenosis.
- These and other objects of the present invention are accomplished by providing a delivery catheter for use with a ribbon-type stent comprising an inner member slidably disposed within a sheath. In accordance with the principles of the present invention, the inner member includes a helical ledge that causes the stent to be wound around the inner member with a pitch selected to provide a preselected amount of foreshortening of the stent during deployment, including substantially zero foreshortening.
- In one embodiment, the delivery catheter includes an inner member comprising a elongated flexible shaft having a helical wire affixed to its exterior surface, wherein the pitch of the helical wire is preselected for the stent to be delivered. The size of the gap between adjacent turns of the helical wire preferably causes the adjacent turns of the ribbon-type stent, when wound about the inner member, to overlap. The helical wire provides a ledge or abutment surface against which the ribbon-type stent may be urged during winding of the stent to its reduced-diameter delivery configuration. The helical wire may be arranged so either the proximal-facing or distal-facing surface of the helical wire defines the ledge.
- Alternatively, the inner member may have the abutment surface integrally formed with the exterior surface of the inner member. This may be accomplished by braiding a plurality of wire strands together, wherein one of the wire strands has a larger cross-section than the others. In this case, the larger cross-section wire protrudes from the inner member to define the helical ledge on the surface of the inner member. As a further alternative, the helical ledge may be integrally formed with an inner member formed from a suitable polymer, e.g., by extrusion or molding.
- The delivery catheter of the present invention optionally may include an inflatable balloon disposed adjacent to the distal end of the inner member, and distal to the distal end of the sheath. When so provided, the inflatable balloon may be deployed to engage a portion of a vessel so that proximal withdrawal of the sheath does not inadvertently result in axial displacement of the delivery catheter or stent relative to the vessel. Advantageously, the balloon distributes the load created by proximal withdrawal of the sheath uniformly to the circumference of the vessel, thereby reducing local stress concentrations during deployment of the stent that might otherwise arise where a partially-deployed stent contacts the vessel wall. The inner member may in addition include means for engaging a distal section of the stent against axial displacement during proximal retraction of the sheath.
- Methods of making and using the delivery catheter of the present invention also are provided.
- Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments, in which:
-
FIG. 1 is a perspective view of a vascular prosthesis suitable for use with the delivery catheter of the present invention; -
FIG. 2 is a drawing depicting foreshortening of a ribbon-type stent as encountered with previously-known delivery systems as the stent expands from a contracted delivery configuration to an expanded deployed configuration; -
FIG. 3 is a drawing depicting a ribbon-type stent unrolled to a flat configuration and projected onto an expanded deployed configuration (for clarity, only a single turn is shown, although it will be understood that in the deployed configuration the stent includes multiple turns); -
FIG. 4 is a drawing depicting trigonometric relationships between the wrap angle of the stent ofFIG. 3 and width of the stent; -
FIG. 5 is a side sectional view of a prior art delivery system having an inner member disposed within a sheath for relative sliding motion therebetween; -
FIG. 6 is a perspective view of a distal portion of an inner member for a delivery catheter constructed in accordance with the principles of the present invention; -
FIG. 7 is a side view of a distal portion of another inner member of a delivery catheter of the present invention, wherein the helical ledge is integrally formed with the inner member; -
FIG. 8 is a side view illustrating an optional balloon that may be used with the delivery catheter of the present invention to enhance stent placement; and -
FIGS. 9A to 9D are side-sectional views showing a method of delivering the vascular prosthesis ofFIG. 1 using the delivery catheter of the present invention. - The present invention is directed to a delivery catheter for use with an implantable vascular prosthesis configured for use in a wide range of applications, such as treating aneurysms, maintaining patency in a vessel, and allowing for the controlled delivery of therapeutic agents to a vessel wall. Advantageously, the delivery catheter of the present invention may be used to deliver a vascular prosthesis having a helical ribbon portion joined, at its distal end, to a radially self-expanding anchor portion, such as depicted in
FIG. 1 . The delivery catheter provides enhanced accuracy in delivering the stent by providing a predictable degree of foreshortening of the stent, including substantially zero foreshortening. Additionally, the delivery catheter optionally may include a balloon that reduces inadvertent axial movement of the delivery catheter during stent deployment and/or means that reduce axial displacement of the vascular prosthesis relative to the delivery catheter. - Referring to
FIG. 1 , a preferred vascular prosthesis suitable for use with the delivery catheter of the present invention is described. As used in this specification, the terms “vascular prosthesis” and “stent” are used interchangeably.Vascular prosthesis 10 is described in copending commonly assigned U.S. patent application Ser. No. 10/342,427, filed Jan. 13, 2003, and compriseshelical section 12 anddistal section 14, each capable of assuming contracted and deployed states. InFIG. 1 ,helical section 12 anddistal section 14 are each depicted in their respective deployed states. -
Vascular prosthesis 10 preferably is formed from a solid tubular member comprising a shape memory material, such as nickel-titanium alloy (commonly known in the art as Nitinol). The solid tubular member then is laser cut, using techniques that are per se known in the art, to a desired deployed configuration, as depicted inFIG. 1 . An appropriate heat treatment, per se known in the art, then may be applied tovascular prosthesis 10 while the device is held in the desired deployed configuration (e.g., on a mandrel), thus conferring a desired deployed configuration tovascular prosthesis 10 when self-deployed. -
Distal section 14 preferably has a generally zig-zag configuration in the deployed state, wherein the zig-zag configuration preferably is formed by laser cutting a solid tube to form a pattern comprising plurality ofarcuate struts 18 joined atapices 20.Distal section 14 is designed to be deployed from the delivery catheter of the present invention first to fix the distal end of the stent at a desired known location within a vessel. In this manner, subsequent deployment ofhelical section 12 of the stent may be accomplished with greater accuracy. -
Helical section 12 preferably comprises a helical mesh configuration that includes a plurality of substantially flat turns 22. Plurality ofturns 22 may include a multiplicity of openings, as illustrated byopenings 24. It should be understood that the configuration ofhelical section 12 depicted inFIG. 1 is merely illustrative, and other patterns may be advantageously employed.Helical section 12 is coupled todistal section 14 atjunction 26. - Referring now to
FIG. 2 , the problem of stent foreshortening as heretofore encountered with ribbon-type stents is described. As used in this specification, “foreshortening” refers to the length change of the stent between its contracted delivery configuration and its expanded deployed configuration. More specifically, the contracted delivery configuration, depicted in the upper portion ofFIG. 2 , corresponds to the state wherein consecutive turns of the stent have been tightly wrapped around adjacent turns to reduced the diameter of the stent to diameter d1 and length of L1, suitable for transluminal delivery to a target location within a vessel. In the deployed configuration, the stent is permitted to expand to its nominal working diameter, and has a diameter d2 and length of L2, suitable for supporting a target location within a vessel. “Foreshortening” is defined as the difference between the lengths L1 and L2. - In most interventional procedures, satisfactory stent placement requires predictable placement of the distal and proximal ends of the stent within a target vessel. Previously-known ribbon-type self-deploying stents, however, have encountered limited clinical acceptance due to problems associated with foreshortening and inaccurate placement.
- Specifically, previously-known ribbon-type stents often are wound down around a delivery catheter in either an “edge to edge” manner (where the edges of adjacent turns lie next to one another) or with an overlap (or “shingled”), and then covered with a sheath that restrains the stent in the contracted delivery configuration. When wound “edge to edge,” the stent may be significantly longer in the contracted delivery configuration than in the deployed configuration, and thus result in significant foreshortening when deployed.
- On the other hand, when the turns of the stent are permitted to overlap in the contracted delivery configuration, the turns of the stent may lock or bind within the delivery system during deployment. Further still, in either method of contracting the stent to its contracted delivery configuration, the stent has a tendency to jump or hop forwards or backwards when deployed, resulting in poor control. Thus, previously-known ribbon-type stents generally are perceived to be capable of less accurate deployment than conventional balloon expandable stents.
-
Vascular prosthesis 10 ofFIG. 1 is designed to address the issue of movement of the distal end of the stent. In particular,distal section 10 functions as a anchor that fixes the distal end of the stent to the vessel wall. The delivery catheter of the present invention provides the rest of the solution to the placement problem by controlling winding of the stent to a predetermined contracted delivery configuration, and likewise controlling unwinding of the stent during deployment to mitigate foreshortening. - In accordance with the principles of the present invention, it has been discovered that certain trigonometric relationships may be utilized whereby the sent may be wrapped to its reduced delivery diameter, and experience little or no foreshortening during deployment. These relationships are derived below, and then implemented in the delivery catheters of the present invention, as set forth below.
- Referring now to the lower portion of
FIG. 3, 30 previously-known ribbon-type stent is depicted in an unrolled, flattened configuration. When deployed, as schematically depicted by the single turn in the upper portion of theFIG. 3 , thestent 30′ comprises a strip of material wrapped cylindrically at a diameter (d) over an axial length (L) for a number of revolutions (n). The strip is wrapped at a wrap angle (θ), which may be measured from a plane normal to the axis of the helix. - The strip has a width (ω) and an edge length (E); these are physical characteristics of the stent that do not change. On the other hand, the diameter (d), wrap angle (θ), number of revolutions (n), and axial length (L) are interrelated characteristics that vary depending upon the helical configuration of the stent. For example, the diameter of the stent varies between the contracted delivery configuration and deployed configuration, which as shown in
FIG. 2 also may effect the wrap angle, number of revolutions, and axial length. - From inspection of
FIG. 3 , it can be seen that the axial length of the stent in the helical configuration is L plus the proximal-most part of the projected strip width. This additional length may be computed as depicted inFIG. 4 , using a right triangle in which one leg is the strip width (ω), and the hypotenuse is the strip width projected onto the helical axis of the stent. Because the angle on the right side of this triangle is equal to the wrap angle (θ), the strip width projected onto the helical axis of the stent is equal to ω/cos θ. The total length of the stent in the helical configuration is therefore L+ω/cos θ. In addition, it will be observed that, as wrap angle θ increases, the projected width of the strip also increases. - Referring now to
FIGS. 2 and 3 , foreshortening may be computed as the change in the axial length of the stent as it transitions from one diameter (d1) to another (d2) during deployment:
F=(L 1 +ω/cosθ 1)−(L 2+ω/cosθ2)
F=(L 1 −L 2)+(ω/cosθ1−ω/cosθ2)
From inspection ofFIG. 3 , it can be seen that edge length E, axial length L and wrap angle θ are related by the trigonometric relationship:
L=E sinθ
Substituting this relationship into foregoing equation for foreshortening provides:
F=(E sinθ1 −E sinθ2)+(ω/cosθ1−ω/cosθ2)
F=E(sinθ1−sinθ2)+ω(1/cosθ1 −1/cosθ 2) - Of primary interest in the context of the present invention is the case where there is no foreshortening (F=0) when the stent transitions from diameter d1 to diameter d2. By setting the above equation equal to zero, it will be observed that the edge component of the equation E(sinθ1−sinθ2) and the width component ω(1/cosθ1−1/cosθ2) must either be equal to zero, or be equal and opposite. For meaningful wrap angles (0<θ<90), both components will always have the same sign. Thus, in order for the equation to balance, both components of the equation must be equal to zero. This leads to the conclusion that for there to be no foreshortening during stent deployment, the two wrap angles must be equal: θ1=θ2. Accordingly, for a stent wrapped into a helical configuration, where strip width ω and total edge length E are constant, the amount of foreshortening between two different configurations is dependant on wrap angle alone. Thus, to eliminate foreshortening between any two helical configurations, both configurations must have the same wrap angle θ.
- Referring to
FIG. 5 , previously-knowndelivery catheter 40 suitable for use in deploying a ribbon-type stent is described.Delivery catheter 40 is disclosed, e.g., in U.S. Pat. No. 4,665,918 to Garza et al., and includesinner member 41 havingcentral lumen 42,nose cone 43 andsheath 44.Catheter 41 includes recessedportion 45 that cooperates withsheath 44 to retain the stent in its contracted delivery configuration for transluminal delivery.Delivery catheter 40 also may comprisefluid delivery lumen 47, which may be used to deliver chilled saline via one ormore ports 48 to the stent during delivery. - With respect to
FIG. 6 ,delivery catheter 50, constructed in accordance with the principles of the present invention, is described.Delivery catheter 50 includessheath 51 andinner member 52 that implements the rule described hereinabove to mitigate or eliminate foreshortening by imposing on the stent, by imposing on the stent in the contracted delivery configuration the wrap angle θ that the stent will have in the deployed configuration. -
Inner member 52 illustratively comprises braidedwire tube 53 havinghelical wire 54 affixed to its outer surface to formhelical ledge 55, for example, using a biocompatible adhesive or solder. Alternatively,helical wire 54 may be laminated to the outer surface of braidedwire tube 53 using a polymeric layer, orinner member 52 itself may be formed by sandwiching a helical wire between inner and outer polymeric layers. During wrapping of a stent ontoinner member 52, either a proximal or distal edge of the stent is abutted againsthelical ledge 55, so that adjacent turns of the stent overlap one another. Alternatively, braidedtube 53 andhelical wire 54 could be replaced with an inner member having an exterior surface including an integrally formed ridge. In addition,helical ledge 55 could be formed by other features such as protrusions extending from the surface of the inner member. - Provision of the helical ledge directly on the exterior surface of the inner member as in the embodiment of
FIG. 6 permits a definable deployment length of the stent, namely, zero foreshortening. Advantageously, the helical ledge also provides linear resistance to stent migration whensheath 51 is retracted during stent deployment. This engagement between the turns of the stent and the inner member maintains the linear stability of the stent, and reduces the risk that overlapping turns of the stent do not bunch up or seize against the interior surface of the sheath. Moreover, the helical ledge ensures that the stent unwinds on its axis but does not experience significant linear change along the axis. - Use of the delivery catheter of
FIG. 6 is as follows: starting at one end of the stent andhelical ledge 55, the stent is wound around the inner member to its contracted delivery configuration while an edge of the stent is abutted againstledge 55. This causes each subsequent turn of the stent to overlap the preceding turn. The amount of overlap of adjacent turns of the stent is defined by the helical ledge, and is a feature of the particular design of the stent. When the stent is wound down to its contracted delivery configuration,sheath 51 is advanced over the stent and inner member to retain the stent in its contracted delivery configuration. When loaded in the delivery catheter, the length of the stent is the same as the length of the stent in the deployed configuration. - The specific steps for winding the stent onto the inner member in a proximal to distal direction are as follows: First, the tail of the stent is located and fixed at the proximal end of the stent area of the inner member with the distal edge of the stent abutted against the helical ledge. Next, the stent is wrapped around the inner member using the helical ledge to control the pitch and overlap of the stent. The sheath is then slid over the stent while being rotated in a direction in which the stent is wrapped. Finally, if a stent as depicted in
FIG. 1 is employed, the anchor portion of the stent is crimped down, and the sheath is slid over the anchor portion to retain the stent in the contracted delivery configuration. When loaded into the delivery catheter in this manner, the helical ledge guides the pitch of the stent as it is wrapped, thus providing a zero foreshortening solution. - While the foregoing method of employing the delivery catheter of the present invention mitigates foreshortening, it does not prevent each individual turn of the stent from sliding proximally with the sheath during stent deployment. Accordingly, another method of using
delivery catheter 50 calls for winding the stent onto the inner member in a distal to proximal direction, as follows: First, the anchor portion of the stent is placed on inner member in a desired location, and the joint between anchor portion and the helical body portion of the stent is temporarily fixed to the inner member. - Next, the proximal portion of the stent is wrapped around the inner member, wherein the proximal edge of the stent is abutted against the helical ledge. When the stent is completely wrapped around the inner member, the sheath is slid over the stent and inner member while rotating the sheath in the direction in which the stent is wound. The sheath is advanced up to the joint where the distal anchor portion of the stent is coupled to the helical proximal portion. The anchor portion then is crimped down onto the inner member, and the sheath is advanced, while being rotated in the direction of the wrap, until it covers the anchor portion. When the stent is loaded in accordance with this method of the present invention, the helical ledge not only mitigates foreshortening, but in addition, the proximal edge of the stent is prevented from sliding in the proximal direction during retraction of the sheath to deploy the stent.
- Referring now to
FIG. 7 , alternativeinner member 52′ of the present invention is described.Inner member 52′ also preferably comprises anelongated braided tube 53′ havinghelical wire 54′ integrally formed with the tube to definehelical ledge 55′.Braid 53′ preferably is sandwiched between polymeric inner and outer liners, and is made up of a plurality of wire members braided together around the inner liner. The wires used to constructbraid 53′ may have flat or round wires cross-sections, and may comprise stainless steel or polymeric strands, e.g., such as polyester or Kevlar, depending on the flexibility and rigidity desired forinner member 53′. In addition, the rigidity of the inner member may be further selected by choice of the wire diameter, number used and the tightness of the pitch of the braid. -
Helical ledge 55′ is formed by increasing the diameter of one of the wires used to construct the braid oftube 53′, so that it protrudes from the exterior surface of the completed inner member. In particular, the number of braid members and the tightness of their pitch may be selected so thathelical wire 54′ formshelical ledge 55′ that imposes a selected wrap angle on the stent when wound in accordance with the above-described methods. As a further alternative, the inner member may be formed of a polymeric material so that its exterior surface includes an integrally formed ledge, e.g., by extrusion or molding. -
Inner member 52′ ofFIG. 7 permits the delivery catheter to be easily customized during manufacture to provide a desired degree of foreshortening of the stent, including zero foreshortening. In addition,inner member 52′ avoids the manufacturing difficulties inherent in the design ofFIG. 6 , by eliminating the step of affixing the helical wire to the inner member. Still further, inclusion ofhelical wire 54′ inbraided tube 53′ over the length of the inner member advantageously provides for better interaction between the inner member and sheath by providing fewer points of contact therebetween and therefore less frictional engagement between the two members. - Further in accordance with the principles of the present invention, it is possible to adjust the pitch of the helical ledge that imposes the wrap angle on the stent in the contracted delivery configuration to provide a desired degree of foreshortening of the stent during deployment, including the option of having the stent increase in length. Returning to the analytical framework set forth above, a foreshortening ratio (f) may be defined as the ratio of axial length lost during deployment of the stent. This term may be defined mathematically as:
- Because the change in projected body width is generally small compared to the change in axial length of the stent, the foregoing equation may be simplified by neglecting the proximal projected strip width terms, resulting in:
Again substituting
L=E sinθ
into the above equation yields:
Thus, the amount of foreshortening between two different helical configurations may be determined by selection of the wrap angles θ1 and θ2 to provide any desired degree of foreshortening or length increase of the stent as may be desired. - In addition to the above-noted potential issues with ribbon-type stents, it also is possible that movement of the sheath of the delivery catheter may inadvertently cause the delivery catheter to translate proximally within the vessel prior to deployment of the prosthesis, thereby leading to reduced accuracy of the stent placement. In accordance with yet another aspect of the present invention, the delivery catheter of the present invention is configured to reduce the possibility of inadvertent axial translation of the delivery catheter during an initial phase of stent deployment, i.e., prior to deployment of
distal section 14 of the stent ofFIG. 1 . - Referring now to
FIG. 8 ,inner member 60 of the present invention includes a portion defining a helical ledge, as in the embodiments ofFIGS. 5 and 6 , and further comprisingoptional balloon 61 disposed adjacent todistal end 62. Radio-opaque marker 63 is affixed to the distal end ofinner member 60 to make the distal end of the inner member visible under fluoroscopic imaging.Balloon 61 may be formed from compliant or semi-compliant materials, such as nylon or PEBAX, and is inflated via 64.Lumen 64 may be pressurized with fluid from syringe orinflator 65, which may be selectively coupled to the proximal end ofinner member 60, as is known in the art. - In accordance with this aspect of the present invention,
inner member 60 further includes means for engaging the distal end of the distal section ofstent 10. In one preferred embodiment, the means for engaging comprisespolymer layer 66 that has been treated, e.g., by formulation, mechanical abrasion, chemically or by heat treatment, to make the polymer tacky or otherwise enhance the grip of the material. Preferablypolymer layer 66 comprises a proximal shoulder ofballoon 62, although the polymer layer alternatively may be formed and applied separately fromballoon 61. Alternatively,balloon 61 may be omitted, andpolymer layer 66 may be disposed on a portion of the inner member adjacent thedistal end 62. - In operation, the delivery catheter of the present invention, including
inner member 60, is advanced along a guide wire into a vessel containing a treatment area. Positioning of the vascular prosthesis relative to the treatment area is confirmed using radio-opaque marker 63. Once the delivery catheter is placed in the desired location, sheath 51 (seeFIG. 6 ) is retracted proximally to permitdistal section 14 ofstent 10 to deploy. In accordance with the principles of the present invention,polymer layer 66 gripsdistal section 14 ofstent 10, thereby preventingdistal section 14 from being dragged proximally into engagement withhelical section 12 during retraction of the sheath. Instead,polymer section 66 gripsdistal section 14 against axial movement, and permits the distal section to expand radially outward into engagement with the vessel wall once the sheath is retracted. - In addition, either before or after
distal section 14 is expanded into engagement with the vessel wall,balloon 61 may be expanded to contact the vessel wall.Balloon 61 therefore anchorsdistal end 63 of the delivery catheter relative to the vessel wall, so that no inadvertent axial displacement of the delivery catheter arises during proximal retraction of the sheath to releasedistal section 14 orhelical section 12 ofstent 10. - Referring now to
FIGS. 9A to 9D, methods of using delivery catheter 70 of the present invention are described to deliver a stent of the type shown inFIG. 1 .Stent 80 is disposed in its delivery configuration compressed aroundinner member 72 having a helical ledge, and retained bysheath 71.Distal section 81 ofstent 80 is disposed in contact withpolymer layer 73 to prevent relative axial movement therebetween. - As shown in
FIG. 9A , delivery catheter 70 is percutaneously and transluminally advanced alongguide wire 90 untiltip 74 of the catheter is disposed within adjacent healthy tissue of vessel V, distal of lesion L, e.g., as determined by fluoroscopic imaging.Balloon 75 then is inflated to engage the vessel wall and prevent axial displacement of the delivery catheter during subsequent retraction ofsheath 71.Polymer layer 73 engagesdistal section 81 ofstent 80, thereby preventing axial displacement ofdistal section 81 during retraction ofsheath 71. - Referring to
FIG. 9B , afterballoon 75 is inflated to engage the vessel wall,sheath 71 is retracted proximally untildistal section 81 self-expands into engagement with vessel wall within or distal to lesion L. Proximal movement ofsheath 71 may be halted once radio-opaque marker 76 ofsheath 71 is substantially aligned with radio-opaque marker 77 ofinner member 72. When released from the constraint provided bysheath 71, the struts ofdistal section 81 expand in a radial direction to engage the interior of vessel V. - Referring now to
FIG. 9C , afterdistal section 81 is secured to the vessel wall distal of lesion L,sheath 71 is further retracted proximally to cause the helical section ofstent 80 to unwind and deploy to its predetermined shape within vessel V. During proximal retraction ofsheath 71, the turns of the helical section of the stent unwind and engage and conform to an inner wall of vessel V in a controlled manner. Becauseinner member 72 includes a helical ledge (not shown) as described hereinabove with respect toFIGS. 5 and 6 , the stent experiences little or no foreshortening. In addition, any forces that might be applied todistal section 81 during retraction ofsheath 71 advantageously are uniformly distributed over the surface ofballoon 75, thereby reducing the risk of insult to the vessel endothelium. Once the last turn of the helical section ofstent 80 is deployed,balloon 75 is deflated, and the sheath optionally may be advanced to coverballoon 75. Delivery catheter 70 then is withdrawn from the patient's vessel, and guidewire 90 is removed. - While preferred illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made therein without departing from the invention. The appended claims are intended to cover all such changes and modifications that fall within the true spirit and scope of the invention.
Claims (45)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/836,909 US7766960B2 (en) | 2004-04-30 | 2004-04-30 | Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use |
US10/925,756 US20050246008A1 (en) | 2004-04-30 | 2004-08-25 | Delivery system for vascular prostheses and methods of use |
EP05737692A EP1755486A2 (en) | 2004-04-30 | 2005-04-22 | Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use |
PCT/US2005/013762 WO2005110283A2 (en) | 2004-04-30 | 2005-04-22 | Delivery system for vascular prostheses and methods of use |
JP2007510820A JP2007535364A (en) | 2004-04-30 | 2005-04-22 | Delivery system for vascular prosthesis and method of use |
EP05744080A EP1755487A2 (en) | 2004-04-30 | 2005-04-22 | Delivery system for vascular prostheses and methods of use |
JP2007510836A JP2007535365A (en) | 2004-04-30 | 2005-04-22 | Delivery catheter for controlling the reduction of a ribbon prosthesis and method of making and using the same |
PCT/US2005/013904 WO2005110284A2 (en) | 2004-04-30 | 2005-04-22 | Delivery catheter that controls foreshortening of ribbon-type prostheses |
US11/154,056 US20060004438A1 (en) | 2004-04-30 | 2005-06-15 | Prosthesis, delivery system and method for neurovascular aneurysm repair |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/836,909 US7766960B2 (en) | 2004-04-30 | 2004-04-30 | Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/925,756 Continuation-In-Part US20050246008A1 (en) | 2004-04-30 | 2004-08-25 | Delivery system for vascular prostheses and methods of use |
US11/154,056 Continuation-In-Part US20060004438A1 (en) | 2004-04-30 | 2005-06-15 | Prosthesis, delivery system and method for neurovascular aneurysm repair |
Publications (2)
Publication Number | Publication Date |
---|---|
US20050246010A1 true US20050246010A1 (en) | 2005-11-03 |
US7766960B2 US7766960B2 (en) | 2010-08-03 |
Family
ID=35188111
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/836,909 Expired - Fee Related US7766960B2 (en) | 2004-04-30 | 2004-04-30 | Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use |
Country Status (4)
Country | Link |
---|---|
US (1) | US7766960B2 (en) |
EP (1) | EP1755486A2 (en) |
JP (1) | JP2007535365A (en) |
WO (1) | WO2005110284A2 (en) |
Cited By (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070255386A1 (en) * | 2006-04-28 | 2007-11-01 | Dirk Tenne | Stent delivery system with threaded engagement and method |
US20080097572A1 (en) * | 2006-10-22 | 2008-04-24 | Idev Technologies, Inc. | Devices and methods for stent advancement |
WO2010042458A1 (en) * | 2008-10-06 | 2010-04-15 | Flexible Stenting Solutions, Inc. | Reconstrainable stent delivery system |
US20100125323A1 (en) * | 2008-11-14 | 2010-05-20 | Medtronic Vascular, Inc. | Coil Stent Delivery System and Method of Use |
US7771463B2 (en) | 2003-03-26 | 2010-08-10 | Ton Dai T | Twist-down implant delivery technologies |
US7803180B2 (en) * | 2005-04-04 | 2010-09-28 | Flexible Stenting Solutions, Inc. | Flexible stent |
US20100274350A1 (en) * | 2009-04-22 | 2010-10-28 | Medinol Ltd. | Helical hybrid stent |
US7862602B2 (en) | 2005-11-02 | 2011-01-04 | Biosensors International Group, Ltd | Indirect-release electrolytic implant delivery systems |
US7947071B2 (en) * | 2008-10-10 | 2011-05-24 | Reva Medical, Inc. | Expandable slide and lock stent |
US8016869B2 (en) | 2003-03-26 | 2011-09-13 | Biosensors International Group, Ltd. | Guidewire-less stent delivery methods |
US8147534B2 (en) | 2005-05-25 | 2012-04-03 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8172894B2 (en) | 2007-01-26 | 2012-05-08 | Reva Medical, Inc. | Circumferentially nested expandable device |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8277500B2 (en) | 2004-12-17 | 2012-10-02 | Reva Medical, Inc. | Slide-and-lock stent |
US20120330402A1 (en) * | 2011-06-24 | 2012-12-27 | Cook Medical Technologies Llc | Helical stent |
US8382825B2 (en) | 2004-05-25 | 2013-02-26 | Covidien Lp | Flexible vascular occluding device |
US8394119B2 (en) | 2006-02-22 | 2013-03-12 | Covidien Lp | Stents having radiopaque mesh |
US8398701B2 (en) | 2004-05-25 | 2013-03-19 | Covidien Lp | Flexible vascular occluding device |
US8460363B2 (en) | 2007-11-30 | 2013-06-11 | Reva Medical, Inc. | Axially-radially nested expandable device |
US8500794B2 (en) | 2007-08-02 | 2013-08-06 | Flexible Stenting Solutions, Inc. | Flexible stent |
US20130204350A1 (en) * | 2003-06-27 | 2013-08-08 | Medinol Ltd. | Helical hybrid stent |
US8512394B2 (en) | 2004-07-21 | 2013-08-20 | Reva Medical Inc. | Balloon expandable crush-recoverable stent device |
US8523936B2 (en) | 2010-04-10 | 2013-09-03 | Reva Medical, Inc. | Expandable slide and lock stent |
US8617235B2 (en) | 2005-08-02 | 2013-12-31 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US8623067B2 (en) | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
US20140114345A1 (en) * | 2012-10-23 | 2014-04-24 | Medtronic Vascular Galway Limited | Flow Obstructor and Transapical Closure Device |
US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9149378B2 (en) | 2005-08-02 | 2015-10-06 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9408732B2 (en) | 2013-03-14 | 2016-08-09 | Reva Medical, Inc. | Reduced-profile slide and lock stent |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9456910B2 (en) | 2003-06-27 | 2016-10-04 | Medinol Ltd. | Helical hybrid stent |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
CN106974751A (en) * | 2009-07-09 | 2017-07-25 | 卡迪纳尔健康515瑞士有限公司 | Rapamycin reservoir eluting stent |
US9750625B2 (en) | 2008-06-11 | 2017-09-05 | C.R. Bard, Inc. | Catheter delivery device |
CN107137168A (en) * | 2017-06-21 | 2017-09-08 | 青岛容商天下网络有限公司 | The degradable recoverable 4D printing organic human body supports of line style and its application method |
CN107233632A (en) * | 2017-06-21 | 2017-10-10 | 青岛容商天下网络有限公司 | Degradable recoverable 4D printings organic human body support of line style and preparation method thereof |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US9956320B2 (en) | 2003-06-27 | 2018-05-01 | Zuli Holdings Ltd. | Amorphous metal alloy medical devices |
US10004618B2 (en) | 2004-05-25 | 2018-06-26 | Covidien Lp | Methods and apparatus for luminal stenting |
US10022255B2 (en) | 2016-04-11 | 2018-07-17 | Idev Technologies, Inc. | Stent delivery system having anisotropic sheath |
CN114206408A (en) * | 2019-06-05 | 2022-03-18 | 施菲姆德控股有限责任公司 | Catheter blood pump and methods of use and manufacture thereof |
US11357571B2 (en) | 2016-02-16 | 2022-06-14 | Pentas Inc. | Stent length estimation device, stent length estimation program, and method of estimating length of stent |
US11931276B2 (en) | 2008-06-11 | 2024-03-19 | C. R. Bard, Inc. | Catheter delivery device |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7018401B1 (en) | 1999-02-01 | 2006-03-28 | Board Of Regents, The University Of Texas System | Woven intravascular devices and methods for making the same and apparatus for delivery of the same |
US7766960B2 (en) | 2004-04-30 | 2010-08-03 | Novostent Corporation | Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use |
US9084694B2 (en) * | 2005-09-09 | 2015-07-21 | Boston Scientific Scimed, Inc. | Coil shaft |
EP3329882B1 (en) | 2006-10-22 | 2023-09-20 | IDEV Technologies, INC. | Methods for securing strand ends and the resulting devices |
US8858613B2 (en) | 2010-09-20 | 2014-10-14 | Altura Medical, Inc. | Stent graft delivery systems and associated methods |
CA2782385A1 (en) | 2009-12-01 | 2011-06-09 | Altura Medical, Inc. | Modular endograft devices and associated systems and methods |
CN103124539B (en) * | 2010-08-02 | 2016-02-24 | 科迪斯公司 | There is the flexible helical stent of different coil region |
US10285833B2 (en) | 2012-08-10 | 2019-05-14 | Lombard Medical Limited | Stent delivery systems and associated methods |
CN104812322B (en) | 2012-12-20 | 2018-12-11 | 雷纳尔动力有限公司 | Multiple spot treats probe and its application method |
US9737426B2 (en) | 2013-03-15 | 2017-08-22 | Altura Medical, Inc. | Endograft device delivery systems and associated methods |
TW201517865A (en) | 2013-08-14 | 2015-05-16 | Vita Technologies Ltd | Methods and apparatuses for treating auto-immune diseases by ablative neuromodulation |
US10849769B2 (en) | 2017-08-23 | 2020-12-01 | Vesper Medical, Inc. | Non-foreshortening stent |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4541681A (en) * | 1983-05-04 | 1985-09-17 | Cordis Corporation | Electrical connection of wire conductor(s) to a terminal pin in an electrode assembly of a pacing lead |
US4553545A (en) * | 1981-09-16 | 1985-11-19 | Medinvent S.A. | Device for application in blood vessels or other difficultly accessible locations and its use |
US4760849A (en) * | 1985-04-10 | 1988-08-02 | Medinvent S.A. | Planar blank and a coil spring manufactured therefrom |
US4768507A (en) * | 1986-02-24 | 1988-09-06 | Medinnovations, Inc. | Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the prevention of arterial restenosis |
US5129910A (en) * | 1991-07-26 | 1992-07-14 | The Regents Of The University Of California | Stone expulsion stent |
US5234437A (en) * | 1991-12-12 | 1993-08-10 | Target Therapeutics, Inc. | Detachable pusher-vasoocclusion coil assembly with threaded coupling |
US5634928A (en) * | 1994-12-07 | 1997-06-03 | Fischell Robert | Integrated dual-function catheter system and method for balloon angioplasty and stent delivery |
US5824052A (en) * | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Coiled sheet stent having helical articulation and methods of use |
US5824053A (en) * | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
US6425915B1 (en) * | 1997-03-18 | 2002-07-30 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
US6478813B1 (en) * | 1997-08-01 | 2002-11-12 | Peter T. Keith | Method for joining grafts in a common body passageway |
US20030069633A1 (en) * | 2000-06-06 | 2003-04-10 | Jacob Richter | Serpentine coiled ladder stent |
US6607551B1 (en) * | 1999-05-20 | 2003-08-19 | Scimed Life Systems, Inc. | Stent delivery system with nested stabilizer |
US6736844B1 (en) * | 1997-03-04 | 2004-05-18 | Bernard Glatt | Helical stent and method for making same |
US7060088B1 (en) * | 1998-11-13 | 2006-06-13 | Cordis Corporation | Stent with improved flexible connecting links |
US7226472B2 (en) * | 2002-10-15 | 2007-06-05 | Boston Scientific Scimed, Inc. | Catheter balloon with advantageous cone design |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7766960B2 (en) | 2004-04-30 | 2010-08-03 | Novostent Corporation | Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use |
-
2004
- 2004-04-30 US US10/836,909 patent/US7766960B2/en not_active Expired - Fee Related
-
2005
- 2005-04-22 WO PCT/US2005/013904 patent/WO2005110284A2/en active Application Filing
- 2005-04-22 EP EP05737692A patent/EP1755486A2/en not_active Withdrawn
- 2005-04-22 JP JP2007510836A patent/JP2007535365A/en not_active Withdrawn
Patent Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4553545A (en) * | 1981-09-16 | 1985-11-19 | Medinvent S.A. | Device for application in blood vessels or other difficultly accessible locations and its use |
US4541681A (en) * | 1983-05-04 | 1985-09-17 | Cordis Corporation | Electrical connection of wire conductor(s) to a terminal pin in an electrode assembly of a pacing lead |
US4760849A (en) * | 1985-04-10 | 1988-08-02 | Medinvent S.A. | Planar blank and a coil spring manufactured therefrom |
US4768507A (en) * | 1986-02-24 | 1988-09-06 | Medinnovations, Inc. | Intravascular stent and percutaneous insertion catheter system for the dilation of an arterial stenosis and the prevention of arterial restenosis |
US5129910A (en) * | 1991-07-26 | 1992-07-14 | The Regents Of The University Of California | Stone expulsion stent |
US5234437A (en) * | 1991-12-12 | 1993-08-10 | Target Therapeutics, Inc. | Detachable pusher-vasoocclusion coil assembly with threaded coupling |
US5634928A (en) * | 1994-12-07 | 1997-06-03 | Fischell Robert | Integrated dual-function catheter system and method for balloon angioplasty and stent delivery |
US6736844B1 (en) * | 1997-03-04 | 2004-05-18 | Bernard Glatt | Helical stent and method for making same |
US5824053A (en) * | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
US6425915B1 (en) * | 1997-03-18 | 2002-07-30 | Endotex Interventional Systems, Inc. | Helical mesh endoprosthesis and methods of use |
US5824052A (en) * | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Coiled sheet stent having helical articulation and methods of use |
US6478813B1 (en) * | 1997-08-01 | 2002-11-12 | Peter T. Keith | Method for joining grafts in a common body passageway |
US7060088B1 (en) * | 1998-11-13 | 2006-06-13 | Cordis Corporation | Stent with improved flexible connecting links |
US6607551B1 (en) * | 1999-05-20 | 2003-08-19 | Scimed Life Systems, Inc. | Stent delivery system with nested stabilizer |
US20030069633A1 (en) * | 2000-06-06 | 2003-04-10 | Jacob Richter | Serpentine coiled ladder stent |
US7226472B2 (en) * | 2002-10-15 | 2007-06-05 | Boston Scientific Scimed, Inc. | Catheter balloon with advantageous cone design |
Cited By (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7771463B2 (en) | 2003-03-26 | 2010-08-10 | Ton Dai T | Twist-down implant delivery technologies |
US8016869B2 (en) | 2003-03-26 | 2011-09-13 | Biosensors International Group, Ltd. | Guidewire-less stent delivery methods |
US9956320B2 (en) | 2003-06-27 | 2018-05-01 | Zuli Holdings Ltd. | Amorphous metal alloy medical devices |
US20130204350A1 (en) * | 2003-06-27 | 2013-08-08 | Medinol Ltd. | Helical hybrid stent |
US9039755B2 (en) * | 2003-06-27 | 2015-05-26 | Medinol Ltd. | Helical hybrid stent |
US9456910B2 (en) | 2003-06-27 | 2016-10-04 | Medinol Ltd. | Helical hybrid stent |
US9603731B2 (en) | 2003-06-27 | 2017-03-28 | Medinol Ltd. | Helical hybrid stent |
US10363152B2 (en) | 2003-06-27 | 2019-07-30 | Medinol Ltd. | Helical hybrid stent |
US10004618B2 (en) | 2004-05-25 | 2018-06-26 | Covidien Lp | Methods and apparatus for luminal stenting |
US10918389B2 (en) | 2004-05-25 | 2021-02-16 | Covidien Lp | Flexible vascular occluding device |
US9855047B2 (en) | 2004-05-25 | 2018-01-02 | Covidien Lp | Flexible vascular occluding device |
US9801744B2 (en) | 2004-05-25 | 2017-10-31 | Covidien Lp | Methods and apparatus for luminal stenting |
US8623067B2 (en) | 2004-05-25 | 2014-01-07 | Covidien Lp | Methods and apparatus for luminal stenting |
US11771433B2 (en) | 2004-05-25 | 2023-10-03 | Covidien Lp | Flexible vascular occluding device |
US10765542B2 (en) | 2004-05-25 | 2020-09-08 | Covidien Lp | Methods and apparatus for luminal stenting |
US9393021B2 (en) | 2004-05-25 | 2016-07-19 | Covidien Lp | Flexible vascular occluding device |
US9295568B2 (en) | 2004-05-25 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US8628564B2 (en) | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
US8617234B2 (en) | 2004-05-25 | 2013-12-31 | Covidien Lp | Flexible vascular occluding device |
US8398701B2 (en) | 2004-05-25 | 2013-03-19 | Covidien Lp | Flexible vascular occluding device |
US9125659B2 (en) | 2004-05-25 | 2015-09-08 | Covidien Lp | Flexible vascular occluding device |
US8382825B2 (en) | 2004-05-25 | 2013-02-26 | Covidien Lp | Flexible vascular occluding device |
US9050205B2 (en) | 2004-05-25 | 2015-06-09 | Covidien Lp | Methods and apparatus for luminal stenting |
US8512394B2 (en) | 2004-07-21 | 2013-08-20 | Reva Medical Inc. | Balloon expandable crush-recoverable stent device |
US8292944B2 (en) | 2004-12-17 | 2012-10-23 | Reva Medical, Inc. | Slide-and-lock stent |
US8277500B2 (en) | 2004-12-17 | 2012-10-02 | Reva Medical, Inc. | Slide-and-lock stent |
US9173751B2 (en) | 2004-12-17 | 2015-11-03 | Reva Medical, Inc. | Slide-and-lock stent |
US9592137B2 (en) | 2005-04-04 | 2017-03-14 | Flexible Stenting Solutions, Inc. | Flexible stent |
US7803180B2 (en) * | 2005-04-04 | 2010-09-28 | Flexible Stenting Solutions, Inc. | Flexible stent |
US9095343B2 (en) | 2005-05-25 | 2015-08-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9198666B2 (en) | 2005-05-25 | 2015-12-01 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10322018B2 (en) | 2005-05-25 | 2019-06-18 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US8147534B2 (en) | 2005-05-25 | 2012-04-03 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8267985B2 (en) | 2005-05-25 | 2012-09-18 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US9381104B2 (en) | 2005-05-25 | 2016-07-05 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US8236042B2 (en) | 2005-05-25 | 2012-08-07 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US8257421B2 (en) | 2005-05-25 | 2012-09-04 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US9204983B2 (en) | 2005-05-25 | 2015-12-08 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10064747B2 (en) | 2005-05-25 | 2018-09-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US8273101B2 (en) | 2005-05-25 | 2012-09-25 | Tyco Healthcare Group Lp | System and method for delivering and deploying an occluding device within a vessel |
US9149378B2 (en) | 2005-08-02 | 2015-10-06 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US8617235B2 (en) | 2005-08-02 | 2013-12-31 | Reva Medical, Inc. | Axially nested slide and lock expandable device |
US8273116B2 (en) | 2005-11-02 | 2012-09-25 | Biosensors International Group, Ltd. | Indirect-release electrolytic implant delivery systems |
US8900285B2 (en) | 2005-11-02 | 2014-12-02 | Biosensors International Group, Ltd. | Covering electrolytic restraint implant delivery systems |
US8974509B2 (en) | 2005-11-02 | 2015-03-10 | Biosensors International Group, Ltd. | Pass-through restraint electrolytic implant delivery systems |
US7862602B2 (en) | 2005-11-02 | 2011-01-04 | Biosensors International Group, Ltd | Indirect-release electrolytic implant delivery systems |
US8579954B2 (en) | 2005-11-02 | 2013-11-12 | Biosensors International Group, Ltd. | Untwisting restraint implant delivery system |
US9610181B2 (en) | 2006-02-22 | 2017-04-04 | Covidien Lp | Stents having radiopaque mesh |
US9320590B2 (en) | 2006-02-22 | 2016-04-26 | Covidien Lp | Stents having radiopaque mesh |
US10433988B2 (en) | 2006-02-22 | 2019-10-08 | Covidien Lp | Stents having radiopaque mesh |
US11382777B2 (en) | 2006-02-22 | 2022-07-12 | Covidien Lp | Stents having radiopaque mesh |
US8394119B2 (en) | 2006-02-22 | 2013-03-12 | Covidien Lp | Stents having radiopaque mesh |
US8690935B2 (en) * | 2006-04-28 | 2014-04-08 | DePuy Synthes Products, LLC | Stent delivery system with threaded engagement and method |
US9089448B2 (en) | 2006-04-28 | 2015-07-28 | DePuy Synthes Products, LLC | Stent delivery system with threaded engagement method |
US20070255386A1 (en) * | 2006-04-28 | 2007-11-01 | Dirk Tenne | Stent delivery system with threaded engagement and method |
US8876881B2 (en) | 2006-10-22 | 2014-11-04 | Idev Technologies, Inc. | Devices for stent advancement |
US20080097572A1 (en) * | 2006-10-22 | 2008-04-24 | Idev Technologies, Inc. | Devices and methods for stent advancement |
US8172894B2 (en) | 2007-01-26 | 2012-05-08 | Reva Medical, Inc. | Circumferentially nested expandable device |
US8540762B2 (en) | 2007-01-26 | 2013-09-24 | Reva Medical, Inc. | Circumferentially nested expandable device |
US8500794B2 (en) | 2007-08-02 | 2013-08-06 | Flexible Stenting Solutions, Inc. | Flexible stent |
US9314354B2 (en) | 2007-11-30 | 2016-04-19 | Reva Medical, Inc. | Axially-radially nested expandable device |
US8460363B2 (en) | 2007-11-30 | 2013-06-11 | Reva Medical, Inc. | Axially-radially nested expandable device |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
US10610389B2 (en) | 2008-05-13 | 2020-04-07 | Covidien Lp | Braid implant delivery systems |
US11109990B2 (en) | 2008-06-11 | 2021-09-07 | C. R. Bard, Inc. | Catheter delivery device |
US9750625B2 (en) | 2008-06-11 | 2017-09-05 | C.R. Bard, Inc. | Catheter delivery device |
US11931276B2 (en) | 2008-06-11 | 2024-03-19 | C. R. Bard, Inc. | Catheter delivery device |
US10010438B2 (en) | 2008-10-06 | 2018-07-03 | Flexible Stenting Solutions, Inc. | Reconstrainable stent delivery system |
US9149376B2 (en) | 2008-10-06 | 2015-10-06 | Cordis Corporation | Reconstrainable stent delivery system |
WO2010042458A1 (en) * | 2008-10-06 | 2010-04-15 | Flexible Stenting Solutions, Inc. | Reconstrainable stent delivery system |
RU2508079C2 (en) * | 2008-10-06 | 2014-02-27 | Флексибл Стентинг Солюшинс, Инк. | System for delivery of self-expanding stent |
US8545547B2 (en) * | 2008-10-10 | 2013-10-01 | Reva Medical Inc. | Expandable slide and lock stent |
US7947071B2 (en) * | 2008-10-10 | 2011-05-24 | Reva Medical, Inc. | Expandable slide and lock stent |
US9066827B2 (en) * | 2008-10-10 | 2015-06-30 | Reva Medical, Inc. | Expandable slide and lock stent |
US20110245909A1 (en) * | 2008-10-10 | 2011-10-06 | Reva Medical, Inc. | Expandable slide and lock stent |
US20140094897A1 (en) * | 2008-10-10 | 2014-04-03 | Reva Medical, Inc. | Expandable slide and lock stent |
US20100125323A1 (en) * | 2008-11-14 | 2010-05-20 | Medtronic Vascular, Inc. | Coil Stent Delivery System and Method of Use |
US8636760B2 (en) | 2009-04-20 | 2014-01-28 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9155639B2 (en) * | 2009-04-22 | 2015-10-13 | Medinol Ltd. | Helical hybrid stent |
US20100274350A1 (en) * | 2009-04-22 | 2010-10-28 | Medinol Ltd. | Helical hybrid stent |
US8657870B2 (en) | 2009-06-26 | 2014-02-25 | Biosensors International Group, Ltd. | Implant delivery apparatus and methods with electrolytic release |
CN106974751A (en) * | 2009-07-09 | 2017-07-25 | 卡迪纳尔健康515瑞士有限公司 | Rapamycin reservoir eluting stent |
US8523936B2 (en) | 2010-04-10 | 2013-09-03 | Reva Medical, Inc. | Expandable slide and lock stent |
US9452068B2 (en) | 2010-04-10 | 2016-09-27 | Reva Medical, Inc. | Expandable slide and lock stent |
US9023095B2 (en) | 2010-05-27 | 2015-05-05 | Idev Technologies, Inc. | Stent delivery system with pusher assembly |
US20120330402A1 (en) * | 2011-06-24 | 2012-12-27 | Cook Medical Technologies Llc | Helical stent |
US10271974B2 (en) * | 2011-06-24 | 2019-04-30 | Cook Medical Technologies Llc | Helical stent |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9877856B2 (en) | 2012-07-18 | 2018-01-30 | Covidien Lp | Methods and apparatus for luminal stenting |
US20140114345A1 (en) * | 2012-10-23 | 2014-04-24 | Medtronic Vascular Galway Limited | Flow Obstructor and Transapical Closure Device |
US9023080B2 (en) * | 2012-10-23 | 2015-05-05 | Medtronic Vascular Galway Limited | Flow obstructor and transapical closure device |
US9301831B2 (en) | 2012-10-30 | 2016-04-05 | Covidien Lp | Methods for attaining a predetermined porosity of a vascular device |
US9114001B2 (en) | 2012-10-30 | 2015-08-25 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US9907643B2 (en) | 2012-10-30 | 2018-03-06 | Covidien Lp | Systems for attaining a predetermined porosity of a vascular device |
US10952878B2 (en) | 2012-10-31 | 2021-03-23 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9452070B2 (en) | 2012-10-31 | 2016-09-27 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US10206798B2 (en) | 2012-10-31 | 2019-02-19 | Covidien Lp | Methods and systems for increasing a density of a region of a vascular device |
US9943427B2 (en) | 2012-11-06 | 2018-04-17 | Covidien Lp | Shaped occluding devices and methods of using the same |
US9157174B2 (en) | 2013-02-05 | 2015-10-13 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9561122B2 (en) | 2013-02-05 | 2017-02-07 | Covidien Lp | Vascular device for aneurysm treatment and providing blood flow into a perforator vessel |
US9408732B2 (en) | 2013-03-14 | 2016-08-09 | Reva Medical, Inc. | Reduced-profile slide and lock stent |
US11357571B2 (en) | 2016-02-16 | 2022-06-14 | Pentas Inc. | Stent length estimation device, stent length estimation program, and method of estimating length of stent |
US10022255B2 (en) | 2016-04-11 | 2018-07-17 | Idev Technologies, Inc. | Stent delivery system having anisotropic sheath |
CN107233632A (en) * | 2017-06-21 | 2017-10-10 | 青岛容商天下网络有限公司 | Degradable recoverable 4D printings organic human body support of line style and preparation method thereof |
CN107137168A (en) * | 2017-06-21 | 2017-09-08 | 青岛容商天下网络有限公司 | The degradable recoverable 4D printing organic human body supports of line style and its application method |
CN114206408A (en) * | 2019-06-05 | 2022-03-18 | 施菲姆德控股有限责任公司 | Catheter blood pump and methods of use and manufacture thereof |
Also Published As
Publication number | Publication date |
---|---|
EP1755486A2 (en) | 2007-02-28 |
WO2005110284A3 (en) | 2007-04-19 |
WO2005110284A2 (en) | 2005-11-24 |
JP2007535365A (en) | 2007-12-06 |
US7766960B2 (en) | 2010-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7766960B2 (en) | Delivery catheter that controls foreshortening of ribbon-type prostheses and methods of making and use | |
US20050246008A1 (en) | Delivery system for vascular prostheses and methods of use | |
EP1784144B1 (en) | Vascular prosthesis having improved flexibility and nested cell delivery configuration | |
JP5863838B2 (en) | Bifurcated stent and method for placement within a body lumen | |
US7666216B2 (en) | Delivery catheter for ribbon-type prosthesis and methods of use | |
AU2005269662B2 (en) | Stent delivery system allowing controlled release of a stent | |
US8002815B2 (en) | Delivery system and method for vascular prosthesis | |
US6773446B1 (en) | Delivery apparatus for a self-expanding stent | |
US6860898B2 (en) | Self-expanding stent with enhanced delivery precision and stent delivery system | |
US6019779A (en) | Multi-filar coil medical stent | |
US20020077693A1 (en) | Covered, coiled drug delivery stent and method | |
US20130123899A1 (en) | Vascular Prosthesis and Methods of Use | |
JP2006513010A5 (en) | ||
JP2006513010A (en) | Vascular prosthesis and methods of use | |
JP2005342539A (en) | Stent delivery system with enhanced delivery precision | |
WO2008112500A2 (en) | Vascular prosthesis and methods of use | |
US20060004438A1 (en) | Prosthesis, delivery system and method for neurovascular aneurysm repair | |
US20040158314A1 (en) | Ribbon-type vascular prosthesis having stress-relieving articulation and methods of use | |
JP2024501049A (en) | Sleeve pullback mechanism | |
WO2005076950A2 (en) | Ribbon-type vascular prosthesis having stress-relieving articulation and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: NOVOSTENT CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ALEXANDER, MILES;THOMPSON, TODD;HUYNH, TIM;AND OTHERS;REEL/FRAME:015449/0738 Effective date: 20040507 |
|
AS | Assignment |
Owner name: COMERICA BANK, MICHIGAN Free format text: SECURITY AGREEMENT;ASSIGNOR:NOVOSTENT CORPORATION;REEL/FRAME:026876/0163 Effective date: 20110831 |
|
REMI | Maintenance fee reminder mailed | ||
FPAY | Fee payment |
Year of fee payment: 4 |
|
SULP | Surcharge for late payment | ||
FEPP | Fee payment procedure |
Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.) |
|
LAPS | Lapse for failure to pay maintenance fees |
Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20180803 |